Loading page…

Report overview

The report describes the company's 2023 launch of its “Bio+” strategy, focused on biotechnology, biofertilizers and soil health. It reports Group revenue of RMB21,728 million and continued R&D expansion, including the transformation of R&D results into new products. The company also reports RMB44.43 million of HSE investment and extensive pollution-prevention and safety initiatives. A separate 2023 Environmental, Social and Governance Report was published simultaneously with the annual report.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2023
Period: 1 January 2023 – 31 December 2023
Publication date: 25 March 2024
Language
Pages
File size
Restatement: Disclosed

Standards & Assurance

No standards or assurance data is available for this report.

ESG & Materiality

ESG data

Indicators available in this report:

Employees
Women on the board

No materiality data is available for this report.

Build your research dataset.

Original reports, structured indicators and machine-readable Markdown, tailored to your project.

Explore our services